Financhill
Back

Ligand Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

LGND
Ligand Pharmaceuticals, Inc.

Last Price:
$200.02
Seasonality Move:
4.34%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is relatively stagnant and LGND is experiencing slight buying pressure.

Ligand Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 199.64 Buy
20-day SMA: 204.92 Sell
50-day SMA: 198.1 Buy
200-day SMA: 176.56 Buy
8-day EMA: 200.07 Sell
20-day EMA: 201.52 Sell
50-day EMA: 199.39 Buy
200-day EMA: 177.22 Buy

Ligand Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 48.61 Sell
Chaikin Money Flow: 97615 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (198.65 - 210.81) Sell
Bollinger Bands (100): (189.54 - 205.56) Buy

Ligand Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Ligand Pharmaceuticals, Inc. Stock

Is Ligand Pharmaceuticals, Inc. Stock a Buy?

LGND Technical Analysis vs Fundamental Analysis

Sell
47
Ligand Pharmaceuticals, Inc. (LGND) is a Sell

Is Ligand Pharmaceuticals, Inc. a Buy or a Sell?

Ligand Pharmaceuticals, Inc. Stock Info

Market Cap:
4B
Price in USD:
199.93
Share Volume:
221.9K

Ligand Pharmaceuticals, Inc. 52-Week Range

52-Week High:
227.92
52-Week Low:
93.58
Sell
47
Ligand Pharmaceuticals, Inc. (LGND) is a Sell

Ligand Pharmaceuticals, Inc. Share Price Forecast

Is Ligand Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Ligand Pharmaceuticals, Inc.

Is Ligand Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.27 per share.

Technical Analysis of Ligand Pharmaceuticals, Inc.

Should I short Ligand Pharmaceuticals, Inc. stock?

* Ligand Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.